Skip to main content
Zura Bio Ltd logo

Zura Bio Ltd — Investor Relations & Filings

Ticker · ZURA ISIN · KYG507521071 LEI · 549300LQXD6M2MIQFN24 US Manufacturing
Open in API
Filings indexed 394 across all filing types
Latest filing 2023-11-13 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing US ZURA

About Zura Bio Ltd

https://zurabio.com/

Zura Bio Ltd. is a multi-asset, clinical-stage biotechnology company focused on developing novel medicines for severe autoimmune and inflammatory disorders. The company's strategy centers on dual-pathway biology, aiming to create transformative solutions for patients whose needs are not adequately met by single-pathway medicines. Its development portfolio includes the therapeutic candidates tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880). Zura Bio's mission is to enhance patient well-being by developing innovative dual-pathway antibody therapies that demonstrate efficacy, safety, and dosing convenience for challenging immunological conditions.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2023
2023-11-13 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 24, 2023, by Zura Bio Limited. The key content is the disclosure of an Investor Presentation (Exhibit 99.1) that the company began using in presentations to banks and analysts. The text explicitly states that the presentation is incorporated by reference and is intended for use during the fiscal year ending December 31, 2023. The document is primarily an announcement of the filing and availability of the Investor Presentation rather than the presentation itself or a detailed financial report. The length of the document is about 5065 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE, this document should be classified as an Investor Presentation (IP) filing type, as it is the actual presentation being filed and referenced, not just an announcement of its publication. The confidence in this classification is high given the explicit mention and the nature of the filing.
2023-10-25 English
424B7
Capital/Financing Update Classification · 100% confidence The document is a 'Prospectus Supplement No. 1' filed pursuant to Rule 424(b)(7) related to the resale of shares and warrants of Zura Bio Limited. It updates the selling securityholders information in a previously filed prospectus dated September 14, 2023. The document focuses on the resale of securities and the update of selling securityholders, which is typical of capital raising or financing activities. There is no indication of financial statements, audit information, management discussion, or other report types. The document is a supplement to a prospectus, which is a disclosure document used in capital markets to inform investors about securities offerings. Therefore, this filing is best classified as a Capital/Financing Update (CAP).
2023-10-16 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-10-02 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 22, 2023, by Zura Bio Limited. The key content is under Item 5.02, which details the departure and appointment of directors, specifically the appointment of Parvinder Thiara to the Board of Directors. There is no financial data or report content; the document is an announcement of a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 4498 characters, which is consistent with a typical 8-K announcement of management changes rather than a full report. Therefore, the correct classification is MANG with high confidence.
2023-10-02 English
Regulatory Filings 2023
Regulatory Filings
2023-09-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.